Multi-state medical marijuana operator Vireo Health International, Inc. (CNSX: VREO; OTCQX: VREOF) today announced a familiar name from the cannabis industry will helm the company's board going forward. Following his ouster from the Canopy Growth CEO position at the behest of major investor Constellation Brands, Bruce Linton will now move into the role of executive chairman at Vireo Health. Linton will work with Vireo\u2019s current Chief Executive Officer Kyle Kingsley to oversee the company\u2019s M&A, capital raising, and overall strategic direction. For more on this deal check out Capital 10X's interview with Bruce Linton and Kyle Kingsley here. In exchange for his work as executive chairman, Linton will be compensated through three tranches of incentive warrants for a total of 15 million shares. That compensation will come in three staggered offerings, including 10 million at the company\u2019s $1.02 share price from close of business yesterday, as well as 2.5 million at\u00a0$3.81 a share and the remaining 2.5 million at\u00a0$5.86. Discussing his reasoning behind joining the Vireo team out of all the cannabis companies currently seeking new board members and senior management, Linton issued this statement today: Beyond the attractive collection of strategic assets and intellectual property that Dr. Kingsley has assembled, I have taken this role because I share the company\u2019s ambitious vision for the future of cannabis. We are confident Vireo can become a top US producer and distributor of high-margin, proprietary products within the next several years and create unprecedented long-term shareholder value. Although reporting strong revenue numbers back in September, Vireo also saw a $1.9 million loss and the company stock has been on the same downward trend seen by the rest of the industry since the spring. Vireo\u2019s stock has declined from a high of $4.90 back in early April to a price of $1.30 as of Thursday afternoon. Senior management changes have become more frequent in recent months as the North American cannabis industry struggles with low revenue, high expansion costs, and price undercuts from non-licensed sources. TerrAscend\u00a0Corp. (CSE: TER; OTCQX: TRSSF) for instance recently brought on a\u00a0new executive chairman last week to oversee operations and directly work alongside the company\u2019s CEO and existing board chair. In other Vireo news, the company just hosted the grand opening ceremony for a new Green Goods\u00a0dispensary\u00a0location in Bethlehem, PA yesterday.